Luqman Dad, MD
Radiation Oncology · Annapolis, MDNPI 1013136886
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (33.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by AstraZeneca at 34.3% of the total. Reporting peaked in 2019 at $2,766 and has fallen 95.1% since, to $136 in 2025.
Across 73 payments — averaging $106.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Astrazeneca UK Limited$1K
- Brainlab, Inc.$1K
- Elekta, Inc.$703
- Siemens Medical Solutions USA, Inc.$369
- Tactile Systems Technology Inc$196
- plus $1K from 26 others
Across 3 payments — averaging $9414.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$28K
What the payments were for
- Consulting fees$2,63434%
- Travel & lodging$2,53733%
- Food & beverage$2,59833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 3 | $2,662 |
| Astrazeneca UK Limited | 7 | $1,404 |
| Brainlab, Inc. | 5 | $1,362 |
| Elekta, Inc. | 3 | $703 |
| Siemens Medical Solutions USA, Inc. | 2 | $369 |
| Tactile Systems Technology Inc | 5 | $196 |
| Sanofi | 5 | $115 |
| GT Medical Technologies, Inc | 1 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Boston Scientific | 3 | $75 |
| Johnson & Johnson(2 entities) | 3 | $72 |
| Eisai Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Merck | 3 | $43 |
| Pharmaessentia USA Corporation | 2 | $42 |
| Tersera Therapeutics LLC | 1 | $37 |
| Bayer | 2 | $34 |
| Novartis | 2 | $32 |
| Seagen Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Global Blood Therapeutics, Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Adaptive Biotechnologies Corporation | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Array Biopharma Inc | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$3,130
- Varian Ethos Treatment Planning$198
- Flexitouch Plus$136
- Nimbl$136
- GammaTile$114
How this compares
$7,769 in reported general payments places this provider in the 85th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $206 |
| Dexamethasone | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Annapolis
- Angel ToranoAnnapolis$675
- Mary YoungAnnapolis$552
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Robert BrooklandTowson$34K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- John MansuetiBerlin$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.